Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$3.11 - $6.63 $136,933 - $291,918
-44,030 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$5.14 - $6.84 $280,489 - $373,258
-54,570 Reduced 55.34%
44,030 $273,000
Q3 2021

Nov 12, 2021

BUY
$5.34 - $9.87 $322,536 - $596,148
60,400 Added 158.12%
98,600 $530,000
Q2 2021

Aug 13, 2021

BUY
$6.41 - $10.17 $244,862 - $388,494
38,200 New
38,200 $368,000
Q4 2020

Feb 12, 2021

SELL
$3.11 - $5.3 $251,468 - $428,547
-80,858 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$3.18 - $4.57 $30,776 - $44,228
9,678 Added 13.6%
80,858 $289,000
Q2 2020

Aug 12, 2020

SELL
$2.71 - $5.47 $101,486 - $204,846
-37,449 Reduced 34.47%
71,180 $317,000
Q1 2020

May 15, 2020

BUY
$1.77 - $5.4 $192,273 - $586,596
108,629 New
108,629 $328,000

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $145M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.